194 related articles for article (PubMed ID: 12776794)
21. Characteristics and risk factors of acetaminophen-induced hepatitis in Taiwan.
Wang K; Huang YS; Deng JF; Yang CC; Ger J; Tsai WJ; Wu JC; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):369-75. PubMed ID: 10389295
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration.
Grypioti AD; Theocharis SE; Papadimas GK; Demopoulos CA; Papadopoulou-Daifoti Z; Basayiannis AC; Mykoniatis MG
Arch Toxicol; 2005 Aug; 79(8):466-74. PubMed ID: 15995853
[TBL] [Abstract][Full Text] [Related]
23. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study.
Kuffner EK; Green JL; Bogdan GM; Knox PC; Palmer RB; Heard K; Slattery JT; Dart RC
BMC Med; 2007 May; 5():13. PubMed ID: 17537264
[TBL] [Abstract][Full Text] [Related]
24. Outpatient N-acetylcysteine treatment for acetaminophen poisoning: an ethical dilemma or a new financial mandate?
Dean BS; Bricker JD; Krenzelok EP
Vet Hum Toxicol; 1996 Jun; 38(3):222-4. PubMed ID: 8727227
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network.
James LP; Wilson JT; Simar R; Farrar HC; Kearns GL; Simpson PM; Hinson JA; Pumford NR;
Clin Pediatr (Phila); 2001 May; 40(5):243-8. PubMed ID: 11388672
[TBL] [Abstract][Full Text] [Related]
26. Severe hepatotoxicity after therapeutic doses of acetaminophen.
Moling O; Cairon E; Rimenti G; Rizza F; Pristerá R; Mian P
Clin Ther; 2006 May; 28(5):755-60. PubMed ID: 16861097
[TBL] [Abstract][Full Text] [Related]
27. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen.
King JP; Davis TC; Bailey SC; Jacobson KL; Hedlund LA; Di Francesco L; Parker RM; Wolf MS
Am J Prev Med; 2011 Jun; 40(6):593-8. PubMed ID: 21565649
[TBL] [Abstract][Full Text] [Related]
28. Supratherapeutic dosing of acetaminophen among hospitalized patients.
Zhou L; Maviglia SM; Mahoney LM; Chang F; Orav EJ; Plasek J; Boulware LJ; Bates DW; Rocha RA
Arch Intern Med; 2012 Dec; 172(22):1721-8. PubMed ID: 23401887
[TBL] [Abstract][Full Text] [Related]
29. Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases.
Heard K; Bui A; Mlynarchek SL; Green JL; Bond GR; Clark RF; Kozer E; Koff RS; Dart RC
Am J Ther; 2014; 21(3):174-83. PubMed ID: 22407198
[TBL] [Abstract][Full Text] [Related]
30. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose.
Woo OF; Mueller PD; Olson KR; Anderson IB; Kim SY
Ann Emerg Med; 2000 Apr; 35(4):363-8. PubMed ID: 10736123
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol.
Heard K; Green JL; Bailey JE; Bogdan GM; Dart RC
Aliment Pharmacol Ther; 2007 Jul; 26(2):283-90. PubMed ID: 17593074
[TBL] [Abstract][Full Text] [Related]
32. [Severe hepatocellular damage after administration of paracetamol and chlorzoxazone in therapeutic dosage].
Kronenberg A; Krähenbühl S; Zimmermann A; Streuli R
Praxis (Bern 1994); 1998 Oct; 87(41):1356-60. PubMed ID: 9828666
[TBL] [Abstract][Full Text] [Related]
33. Trends in hepatic injury associated with unintentional overdose of paracetamol (Acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000-7.
Bond GR; Ho M; Woodward RW
Drug Saf; 2012 Feb; 35(2):149-57. PubMed ID: 22149359
[TBL] [Abstract][Full Text] [Related]
34. High dose acetaminophen in narcotic combinations: should there be concern?
Mort JR
S D Med; 2008 Aug; 61(8):294-5. PubMed ID: 18819317
[No Abstract] [Full Text] [Related]
35. [Good use and knowledge of paracetamol (acetaminophen) among self-medicated patients: Prospective study in community pharmacies].
Severin AE; Petitpain N; Scala-Bertola J; Latarche C; Yelehe-Okouma M; Di Patrizio P; Gillet P
Therapie; 2016 Jun; 71(3):287-96. PubMed ID: 27235652
[TBL] [Abstract][Full Text] [Related]
36. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.
Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448
[TBL] [Abstract][Full Text] [Related]
37. Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily?
Ging P; Mikulich O; O'Reilly KM
Age Ageing; 2016 Jul; 45(4):566-7. PubMed ID: 27103600
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity.
Dambach DM; Durham SK; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2006 Mar; 211(2):157-65. PubMed ID: 16081117
[TBL] [Abstract][Full Text] [Related]
39. Reliability of the reported ingested dose of acetaminophen for predicting the risk of toxicity in acetaminophen overdose patients.
Zyoud SH; Awang R; Sulaiman SA
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):207-13. PubMed ID: 21812068
[TBL] [Abstract][Full Text] [Related]
40. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation.
James LP; McCullough SS; Lamps LW; Hinson JA
Toxicol Sci; 2003 Oct; 75(2):458-67. PubMed ID: 12883092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
